Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 4, April 2026

    April 9, 2026

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026

      Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

      April 9, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

      April 9, 2026

      Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

      April 9, 2026

      Is the Secondary Life Insurance Market in the UK Set To Re-Emerge?

      April 9, 2026

      Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital

      March 25, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

      April 9, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

      April 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    DB, DC, and the Spectrum of Scheme Designs In Between

    Longevity and Mortality Risk Transfer September 11, 2024By Mark Stansfield
    Share
    Twitter LinkedIn Email

    As of 7 October, the Royal Mail Collective Pension Plan will launch for Royal Mail employees with over a year’s service. It’s an achievement for all involved and is the first time in decades a new style of pension scheme has been launched in the UK. Embracing collective funding and members all sharing in the gains and losses of investment markets, CDC schemes borrow from both traditional DB and DC schemes. This includes an annual pension and lump sum entitlement on retirement from DB, but members bear the investment risk on their benefits from DC. If DB and DC schemes are on opposite sides of the spectrum, CDC sits near the middle, perhaps leaning towards DC with the risks that members still take. 

    What if legislation promoted the development of further DB/DC-style schemes, taking the best parts of both DB and DC to create schemes that work for all? The adequacy of UK DC pension provision is an industry-wide challenge, with historically generous DB legacy arrangements forming a decreasing part of retirement provision, instead replaced by insufficient DC pension pots, leading to a potential erosion of standards of living in retirement. The industry is looking at maximising output from DC arrangements through illiquid assets and sensible decumulation options, but it seems inevitable that higher contributions through the expansion of auto-enrolment will be in the future. 

    Could the answer instead lie in embracing historic aspects of DB? It’s not hard to envision a win-win-win for employer, member and government. Employer takes on manageable risks with some other form of incentive from the government (lower mandated contributions, NI rebates, etc), the member achieves a better retirement outcome without the abundance of choice on what to do at retirement and there is less reliance on the government to cover future state retirement provision. 

    With a lot of untapped potential in the middle of the UK pensions scheme design spectrum, the important question is what tweaks can be made to current scheme design that makes a ‘DB-lite’ scheme appealing to all stakeholders involved. Below are a few examples that I think could be attractive. 

    • CDC with a no-reduction underpin on pension increases – collective funding with limited downside risk, with employers absorbing the small risk. 
      A big challenge of CDC is the years of poor financial markets, and having to tell members that their pension is reducing. If an employer provided a guarantee against this, it resolves a big challenge of CDC. Whilst CDC is currently designed to have no surplus or deficit, legislative change could allow for deficit reduction contributions over an appropriate period of time to plug a deficit, which would stop when the scheme is funded well enough to provide increases again. This wouldn’t be far off from DB schemes in deficit, except the ability to have nil pension increases whilst in deficit which would limit the downside risk for employers. For a whole of life scheme with a long duration, it is very unlikely that an underpin will bite, and the impact will be reduced in any event. 
    • PPF-level benefits on retirement – guaranteed income above annuity pricing, with the PPF as a safety net. 
      The conversion of say AVCs into a DB pension is an uncommon but feasible option for UK DB schemes. Converting DC benefits at-retirement to a DB pension which provides PPF-level benefits would likely give employees an outcome above annuity purchase, but maintaining a strong level of certainty given the scheme would be underpinned by the PPF. A theoretically strong option, however, is built on moral hazard and is certainly an area TPR will be keeping a close eye on. 
    • Varying DB benefits – mixture of risk sharing of member and employer, getting the balance right with simplicity, costs and member protection. 
      DC benefits have long had a flexibility argument over DB, with annuity purchase allowing members to flex the characteristics of a lifetime pension to match their circumstances. What if legislation allowed members to flex their DB benefits at the point of retirement? This is already possible to an extent with limited restrictions for certain schemes, through pension increase exchanges on pre97 benefits and spouse percentage purchasable at-retirement. What if a member didn’t need a spouse pension, or wanted to trade off all of their pension increases for a flat higher pension on retirement? Schemes could trade typically-expensive risks in inflation and longevity for members getting a benefit that best meets their needs. There are a wide range of scheme designs that have various trade-offs that should fit well along the scheme design spectrum. 

    Whilst the above examples represent very different scheme designs, they all benefit from the power of size and scale. What’s clear from the King’s Speech is that the government are prioritising consolidation within the pensions industry, and the above examples would be even more appealing in a consolidated pensions environment. 

    With change comes opportunity, and the launch of CDC symbolises further opportunity to embrace different scheme design to meet the challenges of future pension provision. The pensions industry will rise to the need to build better pension schemes for the future, but the first step sits with the government, which needs to be bold and ambitious in building the legislative foundation for these scheme designs to flourish. Our call for the government is to embrace the opportunity they have and leave a lasting legacy for future pension provision in the UK. 

    Mark Stansfield is Actuarial Consultant at Hymans Robertson 


    This communication has been compiled by Hymans Robertson LLP® (HR) as a general information summary and is based on its understanding of events as at the date of publication, which may be subject to change. It is not to be relied upon for investment or financial decisions and is not a substitute for professional advice (including for legal, investment or tax advice) on specific circumstances.   

    HR accepts no liability for errors or omissions or reliance on any statement or opinion. Where we have relied upon data provided by third parties, reasonable care has been taken to assess its accuracy however we provide no guarantee and accept no liability in respect of any errors made by any third party.  

    Hymans Robertson LLP is a limited liability partnership registered in England and Wales with registered number OC310282. Authorised and regulated by the Financial Conduct Authority and licensed by the Institute and Faculty of Actuaries for a range of investment business activities.  

    © Hymans Robertson LLP 2023. All rights reserved.

    Any views expressed in this article are those of the author(s) and may not necessarily represent those of Life Risk News or its publisher, the European Life Settlement Association

    2024 - September Commentary Longevity Risk Pension Risk Transfer Volume 3 Issue 9 - September 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026By Greg Winterton

    Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

    April 9, 2026By Greg Winterton

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026By Liam Bodemeaid

    Is the Secondary Life Insurance Market in the UK Set To Re-Emerge?

    April 9, 2026By Greg Winterton
    Latest Issue

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026

    Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market

    April 9, 2026

    Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth

    April 9, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.